Nephros Inc (NEPH) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Nephros Inc (NEPH) has a cash flow conversion efficiency ratio of -0.156x as of March 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($-1.67 Million) by net assets ($10.70 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See how leveraged is Nephros Inc's balance sheet to measure how much of total assets are equity-financed.
Nephros Inc - Cash Flow Conversion Efficiency Trend (2002–2025)
This chart illustrates how Nephros Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check NEPH cash to earnings ratio to evaluate the quality of earnings relative to operating cash generation.
Nephros Inc Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Nephros Inc ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Lung Ming Green Energy Technology Engineering Co Ltd
TW:3018
|
-0.180x |
|
Heimstaden AB Pfd.
ST:HEIM-PREF
|
0.002x |
|
Sound Group Inc.
NASDAQ:SOGP
|
N/A |
|
King River Resources Ltd
AU:KRR
|
-0.015x |
|
Speed Rabbit Pizza SA
PA:MLSRP
|
N/A |
|
Nandan Denim Limited
NSE:NDL
|
0.071x |
|
Cyclone Metals Ltd
AU:CLE
|
-0.088x |
|
Memscap Regpt
PA:MEMS
|
0.048x |
Annual Cash Flow Conversion Efficiency for Nephros Inc (2002–2025)
The table below shows the annual cash flow conversion efficiency of Nephros Inc from 2002 to 2025. For the full company profile with market capitalisation and key ratios, see NEPH company net worth.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | $10.20 Million | $1.65 Million | 0.161x | +381.36% |
| 2024-12-31 | $8.59 Million | $-492.00K | -0.057x | -157.92% |
| 2023-12-31 | $8.36 Million | $827.00K | 0.099x | +127.17% |
| 2022-12-31 | $8.88 Million | $-3.23 Million | -0.364x | -279.03% |
| 2021-12-31 | $14.75 Million | $-1.42 Million | -0.096x | +78.33% |
| 2020-12-31 | $15.57 Million | $-6.90 Million | -0.443x | -49.75% |
| 2019-12-31 | $7.69 Million | $-2.28 Million | -0.296x | +45.05% |
| 2018-12-31 | $6.80 Million | $-3.66 Million | -0.539x | -1264.21% |
| 2017-12-31 | $1.95 Million | $-77.00K | -0.039x | +98.75% |
| 2016-12-31 | $667.00K | $-2.11 Million | -3.166x | -121.11% |
| 2015-12-31 | $2.66 Million | $-3.81 Million | -1.432x | -426.07% |
| 2014-12-31 | $-5.68 Million | $-2.50 Million | 0.439x | -92.52% |
| 2013-12-31 | $-610.00K | $-3.58 Million | 5.874x | +125.91% |
| 2012-12-31 | $-595.00K | $-1.55 Million | 2.600x | +385.08% |
| 2011-12-31 | $1.42 Million | $-1.30 Million | -0.912x | +90.47% |
| 2010-12-31 | $135.00K | $-1.29 Million | -9.570x | -617.41% |
| 2009-12-31 | $1.96 Million | $-2.61 Million | -1.334x | +40.95% |
| 2008-12-31 | $2.53 Million | $-5.72 Million | -2.259x | -166.10% |
| 2007-12-31 | $8.76 Million | $-7.43 Million | -0.849x | -124.38% |
| 2006-12-31 | $-2.10 Million | $-7.30 Million | 3.482x | +470.79% |
| 2005-12-31 | $5.38 Million | $-5.05 Million | -0.939x | -15.62% |
| 2004-12-31 | $9.65 Million | $-7.84 Million | -0.812x | -228.14% |
| 2003-12-31 | $-5.38 Million | $-3.41 Million | 0.634x | +180.58% |
| 2002-12-31 | $-8.00 Million | $-1.81 Million | 0.226x | -- |
About Nephros Inc
Nephros, Inc., a commercial-stage company, develops and sells water filtration solutions for medical and commercial applications in the United States. It offers ultrafiltration products that are used in dialysis centers for the removal of biological contaminants from water and bicarbonate concentrate; and in hospitals for the prevention of infection from waterborne pathogens, such as legionella a… Read more